---
figid: PMC4951756__srep30040-f7
figlink: /pmc/articles/PMC4951756/figure/f7/
number: F7
caption: D2 receptor antagonists (e.g. haloperidol) and D2 receptor partial agonists
  (e.g. aripiprazole) bind with the dopamine D2-like receptor, resulting in the phosphorylation
  of Akt and the subsequent phosphorylation of GSK3β probably via biasedly antagonising
  D2R-mediated β-arrestin2, together with the activation of the Dvl-GSK3β-β-catenin
  pathway (A), which might contribute to the therapeutic effect of antipsychotics.
  On the other hand, antagonism of the D2-like receptors by aripiprazole and haloperidol
  leads to increased expression of GABAA (β-1) receptors probably via the activation
  of PKA activity (indicated as a dashed arrow) (B), and enhanced CREB1 activity via
  the activation of GSK3β activity and PKA activity (C), both of which might also
  be involved in the therapeutic actions of antipsychotics.
pmcid: PMC4951756
papertitle: Chronic administration of aripiprazole activates GSK3β-dependent signalling
  pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats.
reftext: Bo Pan, et al. Sci Rep. 2016;6:30040.
pmc_ranked_result_index: '58276'
pathway_score: 0.9305787
filename: srep30040-f7.jpg
figtitle: Chronic administration of aripiprazole activates GSK3Beta-dependent signalling
  pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats
year: '2016'
organisms: Homo sapiens
ndex: 092e2eec-dec0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4951756__srep30040-f7.html
  '@type': Dataset
  description: D2 receptor antagonists (e.g. haloperidol) and D2 receptor partial
    agonists (e.g. aripiprazole) bind with the dopamine D2-like receptor, resulting
    in the phosphorylation of Akt and the subsequent phosphorylation of GSK3β probably
    via biasedly antagonising D2R-mediated β-arrestin2, together with the activation
    of the Dvl-GSK3β-β-catenin pathway (A), which might contribute to the therapeutic
    effect of antipsychotics. On the other hand, antagonism of the D2-like receptors
    by aripiprazole and haloperidol leads to increased expression of GABAA (β-1) receptors
    probably via the activation of PKA activity (indicated as a dashed arrow) (B),
    and enhanced CREB1 activity via the activation of GSK3β activity and PKA activity
    (C), both of which might also be involved in the therapeutic actions of antipsychotics.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAR1B
  - DVL3
  - CTNNB1
  - PRKACB
  - PRKACG
  - FZD8
  - PRKACA
  - AKT3
  - FZD2
  - AKT1
  - FZD6
  - FZD10
  - FZD9
  - PRKAR1A
  - FZD3
  - AKT2
  - PRKAR2B
  - FZD7
  - FZD5
  - GSK3B
  - FZD4
  - FZD1
  - PRKAR2A
genes:
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: Dvl-3↑
  symbol: DVL3
  source: hgnc_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: p-Akt↑
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: B-catenin↑
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: p-Akt↑
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: p-Akt↑
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: p-GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
chemicals: []
diseases: []
figid_alias: PMC4951756__F7
redirect_from: /figures/PMC4951756__F7
figtype: Figure
---
